{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:15:12Z","timestamp":1754108112666},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40120-023-00516-2","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:10:33Z","timestamp":1687425033000},"page":"1631-1647","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights"],"prefix":"10.1007","volume":"12","author":[{"given":"Mary","family":"Curry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Belter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatou","family":"Sarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Whitmire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Jarecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"516_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1041","volume":"381","author":"J Wise","year":"2023","unstructured":"Wise J. Covid-19: Who declares end of global health emergency. BMJ. 2023;381: p1041.","journal-title":"BMJ"},{"key":"516_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). CDC museum covid-19 timeline. 2023. [cited 2023 May 22]. Available from: https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html."},{"issue":"5","key":"516_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s11606-022-08002-5","volume":"38","author":"A Huggins","year":"2023","unstructured":"Huggins A, Husaini M, Wang F, Waken RJ, Epstein AM, Orav EJ, et al. Care disruption during covid-19: A national survey of hospital leaders. J Gen Intern Med. 2023;38(5):1232\u20138.","journal-title":"J Gen Intern Med"},{"issue":"15","key":"516_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMsb2021088","volume":"383","author":"D Blumenthal","year":"2020","unstructured":"Blumenthal D, Fowler EJ, Abrams M, Collins SR. Covid-19\u2014implications for the health care system. N Engl J Med. 2020;383(15):1483\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"516_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-021-01711-w","volume":"16","author":"HB Radtke","year":"2021","unstructured":"Radtke HB, Klein-Tasman BP, Merker VL, Knight P, Ullrich NJ, Jordan JT, et al. The impact of the covid-19 pandemic on neurofibromatosis clinical care and research. Orphanet J Rare Dis. 2021;16(1):61.","journal-title":"Orphanet J Rare Dis"},{"key":"516_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.588929","volume":"11","author":"B Bertran Recasens","year":"2020","unstructured":"Bertran Recasens B, Rubio MA. Neuromuscular diseases care in the era of covid-19. Front Neurol. 2020;11: 588929.","journal-title":"Front Neurol"},{"key":"516_CR7","unstructured":"US Food and Drug Administration (FDA). Conduct of clinical trials of medical products during the covid-19 pubic health emergency. 2020. [cited 2023 May 20]. Available from: https:\/\/www.fda.gov\/media\/136238\/download."},{"issue":"1","key":"516_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1186\/s12889-020-09301-4","volume":"20","author":"E Monaghesh","year":"2020","unstructured":"Monaghesh E, Hajizadeh A. The role of telehealth during covid-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20(1):1193.","journal-title":"BMC Public Health"},{"issue":"11","key":"516_CR9","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1007\/s00415-022-11273-x","volume":"269","author":"J Helleman","year":"2022","unstructured":"Helleman J, Johnson B, Holdom C, Hobson E, Murray D, Steyn FJ, et al. Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey. J Neurol. 2022;269(11):6003\u201313.","journal-title":"J Neurol"},{"key":"516_CR10","unstructured":"Cure SMA. Clinical Trial Readiness 2023. [cited 2023 May 20]. Available from: https:\/\/www.curesma.org\/clinical-trial-readiness\/."},{"issue":"1","key":"516_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365.","journal-title":"Cell"},{"issue":"3","key":"516_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (smn1) in autosomal recessive spinal muscular atrophy (sma). Hum Mutat. 2000;15(3):228\u201337.","journal-title":"Hum Mutat"},{"issue":"2","key":"516_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51(2):157\u201367.","journal-title":"Muscle Nerve"},{"issue":"8","key":"516_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/archneurol.2011.74","volume":"68","author":"SJ Kolb","year":"2011","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011;68(8):979\u201384.","journal-title":"Arch Neurol"},{"issue":"4","key":"516_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"1","key":"516_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8(1):52.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"516_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27\u201332.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"516_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323.","journal-title":"Arch Neurol"},{"issue":"8","key":"516_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2007;22(8):946\u201351.","journal-title":"J Child Neurol"},{"issue":"9","key":"516_CR20","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","volume":"255","author":"S Piepers","year":"2008","unstructured":"Piepers S, van den Berg LH, Brugman F, Scheffer H, Ruiterkamp-Versteeg M, van Engelen BG, et al. A natural history study of late onset spinal muscular atrophy types 3b and 4. J Neurol. 2008;255(9):1400\u20134.","journal-title":"J Neurol"},{"issue":"3","key":"516_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ene.13534","volume":"25","author":"RI Wadman","year":"2018","unstructured":"Wadman RI, Wijngaarde CA, Stam M, Bartels B, Otto LAM, Lemmink HH, et al. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c\u20134. Eur J Neurol. 2018;25(3):512\u20138.","journal-title":"Eur J Neurol"},{"key":"516_CR22","unstructured":"Centers for Disease Control and Prevention (CDC). National Vital Statistics Reports. 2023. [cited 2023 May 31]. Available from: https:\/\/www.cdc.gov\/nchs\/products\/nvsr.htm."},{"key":"516_CR23","unstructured":"Spinraza prescribing information. Cambridge: Biogen; 2016."},{"key":"516_CR24","unstructured":"Zolgensma prescribing information. Bannockburn: AveXis Inc.; 2019."},{"key":"516_CR25","unstructured":"Evrysdi prescribing information. San Francisco: Genentech; 2020"},{"key":"516_CR26","unstructured":"Cure SMA. Newborn Screening for SMA. 2022. [cited 2023 May 20] Available from: https:\/\/www.curesma.org\/newborn-screening-for-sma\/."},{"key":"516_CR27","unstructured":"American Academy of Pediatrics. Guidance on providing pediatric well-care during covid-19. 2022. [cited 2023 May 26]. Available from: https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/clinical-guidance\/guidance-on-providing-pediatric-well-care-during-covid-19."},{"issue":"19","key":"516_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.15585\/mmwr.mm6919e2","volume":"69","author":"JM Santoli","year":"2020","unstructured":"Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, et al. Effects of the covid-19 pandemic on routine pediatric vaccine ordering and administration - united states, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):591\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"516_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/mus.26903","volume":"62","author":"A Veerapandiyan","year":"2020","unstructured":"Veerapandiyan A, Connolly AM, Finkel RS, Arya K, Mathews KD, Smith EC, et al. Spinal muscular atrophy care in the covid-19 pandemic era. Muscle Nerve. 2020;62(1):46\u20139.","journal-title":"Muscle Nerve"},{"key":"516_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.704928","volume":"12","author":"C Agosto","year":"2021","unstructured":"Agosto C, Salamon E, Giacomelli L, Papa S, Benedetti F, Benini F. Effect of the covid-19 pandemic on children with sma receiving nusinersen: What is missed and what is gained? Front Neurol. 2021;12: 704928.","journal-title":"Front Neurol"},{"issue":"3","key":"516_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.17712\/nsj.2020.3.20200083","volume":"25","author":"F Alghamdi","year":"2020","unstructured":"Alghamdi F, Alshaikh N, Bamaga AK, Bashiri FA, Hundullah K, Alshehri A, et al. A consensus statement on spinal muscular atrophy management in saudi arabia in the context of covid-19. Neurosciences (Riyadh, Saudi Arabia). 2020;25(3):230\u20137.","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"issue":"22","key":"516_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","volume":"94","author":"AC Guidon","year":"2020","unstructured":"Guidon AC, Amato AA. Covid-19 and neuromuscular disorders. Neurology. 2020;94(22):959\u201369.","journal-title":"Neurology"},{"key":"516_CR33","unstructured":"Curry M, Belter L, Paras A, Humbel L, Jarecki J, Schroth M. Spinal muscular atrophy and covid-19: Guidance and resources for providers. 2020. [cited 2022 January 14]. Available from: https:\/\/www.neurologylive.com\/view\/spinal-muscular-atrophy-covid19-guidance-resources-for-healthcare-providers-."},{"issue":"3","key":"516_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/PRM-200768","volume":"13","author":"AT Stratton","year":"2020","unstructured":"Stratton AT, Roberts Iii RO, Kupfer O, Carry T, Parsons J, Apkon S. Pediatric neuromuscular disorders: Care considerations during the covid-19 pandemic. J Pediatr Rehabil Med. 2020;13(3):405\u201314.","journal-title":"J Pediatr Rehabil Med"},{"key":"516_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.607790","volume":"12","author":"YH Tseng","year":"2021","unstructured":"Tseng YH, Chen TH. Care for patients with neuromuscular disorders in the covid-19 pandemic era. Front Neurol. 2021;12: 607790.","journal-title":"Front Neurol"},{"issue":"4","key":"516_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/jcm11040934","volume":"11","author":"DJ Goetschius","year":"2022","unstructured":"Goetschius DJ, Kim Y, Kumar A, Paul D, Naik S. A comprehensive review of neuromuscular manifestations of covid-19 and management of pre-existing neuromuscular disorders in children. J Clin Med. 2022;11(4):934.","journal-title":"J Clin Med"},{"key":"516_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2019.104851","volume":"138","author":"EF Tizzano","year":"2019","unstructured":"Tizzano EF. Treating neonatal spinal muscular atrophy: A 21st century success story? Early Hum Dev. 2019;138: 104851.","journal-title":"Early Hum Dev"},{"issue":"2","key":"516_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mus.27261","volume":"64","author":"BH Lee","year":"2021","unstructured":"Lee BH, Waldrop MA, Connolly AM, Ciafaloni E. Time is muscle: a recommendation for early treatment for preterm infants with spinal muscular atrophy. Muscle Nerve. 2021;64(2):153\u20135.","journal-title":"Muscle Nerve"},{"issue":"8","key":"516_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100725","volume":"3","author":"AAL Motyl","year":"2022","unstructured":"Motyl AAL, Gillingwater TH. Timing is everything: clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy. Cell Rep Med. 2022;3(8): 100725.","journal-title":"Cell Rep Med"},{"key":"516_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/TCRM.S172291","volume":"15","author":"T Dangouloff","year":"2019","unstructured":"Dangouloff T, Servais L. Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives. Ther Clin Risk Manag. 2019;15:1153\u201361.","journal-title":"Ther Clin Risk Manag"},{"issue":"17 Supplement 2","key":"516_CR41","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1212\/WNL.0000000000203015","volume":"100","author":"L Belter","year":"2023","unstructured":"Belter L, Whitmire S, Curry M, Schroth M. Comparing spinal muscular atrophy (sma) outcomes between a patient-reported membership database and a clinical data registry (p2\u20138.012). Neurology. 2023;100(17 Supplement 2):3093.","journal-title":"Neurology"},{"key":"516_CR42","unstructured":"Prior TW, Leach ME, Finanger E. Spinal muscular atrophy. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et al., editors. Genereviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993\u20132023, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"1","key":"516_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-021-02165-w","volume":"17","author":"J Montes","year":"2022","unstructured":"Montes J, Eichinger KJ, Pasternak A, Yochai C, Krosschell KJ. A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities. Orphanet J Rare Dis. 2022;17(1):5.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"516_CR44","doi-asserted-by":"publisher","DOI":"10.2196\/28766","volume":"23","author":"RPA van Eijk","year":"2021","unstructured":"van Eijk RPA, Beelen A, Kruitwagen ET, Murray D, Radakovic R, Hobson E, et al. A road map for remote digital health technology for motor neuron disease. J Med Internet Res. 2021;23(9): e28766.","journal-title":"J Med Internet Res"},{"key":"516_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.735538","volume":"12","author":"MK James","year":"2021","unstructured":"James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote delivery of motor function assessment and training for clinical trials in neuromuscular disease: a response to the covid-19 global pandemic. Front Genet. 2021;12: 735538.","journal-title":"Front Genet"},{"issue":"1","key":"516_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12874-022-01609-6","volume":"22","author":"R Chatters","year":"2022","unstructured":"Chatters R, Cooper CL, O\u2019Cathain A, Murphy C, Lane A, Sutherland K, et al. Learning from covid-19 related trial adaptations to inform efficient trial design-a sequential mixed methods study. BMC Med Res Methodol. 2022;22(1):128.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"516_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40263-022-00899-0","volume":"36","author":"D MacCannell","year":"2022","unstructured":"MacCannell D, Berger Z, Kirschner J, Mercuri E, Farrar MA, Iannaccone ST, et al. Restoration of nusinersen levels following treatment interruption in people with spinal muscular atrophy: simulations based on a population pharmacokinetic model. CNS Drugs. 2022;36(2):181\u201390.","journal-title":"CNS Drugs"},{"issue":"3","key":"516_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/PRM-200748","volume":"13","author":"AE Rabatin","year":"2020","unstructured":"Rabatin AE, Lynch ME, Severson MC, Brandenburg JE, Driscoll SW. Pediatric telerehabilitation medicine: Making your virtual visits efficient, effective and fun. J Pediatr Rehabil Med. 2020;13(3):355\u201370.","journal-title":"J Pediatr Rehabil Med"},{"issue":"5","key":"516_CR49","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00415-020-10149-2","volume":"268","author":"G Costamagna","year":"2021","unstructured":"Costamagna G, Abati E, Bresolin N, Comi GP, Corti S. Management of patients with neuromuscular disorders at the time of the sars-cov-2 pandemic. J Neurol. 2021;268(5):1580\u201391.","journal-title":"J Neurol"},{"key":"516_CR50","doi-asserted-by":"publisher","DOI":"10.2196\/41554","volume":"6","author":"GD Kodjebacheva","year":"2023","unstructured":"Kodjebacheva GD, Culinski T, Kawser B, Coffer K. Satisfaction with telehealth services compared with nontelehealth services among pediatric patients and their caregivers: systematic review of the literature. JMIR Pediatr Parent. 2023;6: e41554.","journal-title":"JMIR Pediatr Parent"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:49:55Z","timestamp":1702648195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00516-2","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}